A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the
prophylaxis of oral candidiasis in patients with AIDS or AIDS related syndromes (group III or
IV, CDC classification)